Skip to content

Arvinas ARVN Business Segments — Other research and development expense

Similar metrics at other companies

Veracyte logo
VCYTReportable Segment — Other research and development expenses
$5.46M+201%
Archer Aviation logo
ACHRReportable Segment — Other research and development expense
$133.3M+51.1%
Crinetics Pharmaceuticals logo
CRNXReportable Segment — Other Research and Development Expense
$8.3M+23.2%
Zymeworks logo
ZYMEReportable Segment — Other research and development expense
$5.63M+3.1%
Travere Therapeutics, Inc. logo
TVTXReportable Segment — Other research and development
$4.84M+9.2%
Inhibrx Biosciences, Inc. logo
INBXReportable Segment — Other Research and Development Expense
$2.91M-7.8%

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$518.11M-4.6%
Enterprise value$439.41M-7.1%
P/S5.8×+4.5×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0.0×
Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:OtherResearchAndDevelopmentExpense.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's business segments — other research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arvinas's business segments — other research and development expense?
Arvinas (ARVN) reported business segments — other research and development expense of $2.4M in Q1 2026.
How has Arvinas's business segments — other research and development expense changed year-over-year?
Arvinas's business segments — other research and development expense decreased by 22.6% year-over-year, from $3.1M to $2.4M.
What is the long-term trend for Arvinas's business segments — other research and development expense?
Over 3 years (2022 to 2025), Arvinas's business segments — other research and development expense has grown at a -15.2% compound annual growth rate (CAGR), from $21M to $12.8M.
What does business segments — other research and development expense mean?
This category includes miscellaneous research and development costs not classified under primary labor or program-specific categories. It provides visibility into the secondary operational costs associated with maintaining a high-tech laboratory and research environment.